Last updated: August 2, 2017
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Overall Status: Completed
Phase
N/A
Condition
Depression (Major/severe)
Mood Disorders
Depression
Treatment
N/AClinical Study ID
NCT02771535
1027/106
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria for the current study are:
informed consent
intention-to-treat-sample of the study Evaluation of Metacognitive Training for Depression (D-MKT) in psychosomatic rehabilitation, DRKS-ID: DRKS00007907 (see Jelinek et al., in press, Psychotherapy and Psychosomatics)
age between 18 and 65 years
diagnosis of a single episode or recurrent major depressive disorder (MDD) or dysthymia (verified by the MINI).
The exclusion criteria were:
- lifetime psychotic symptoms (i.e., hallucinations, delusions, or mania), suicidality (Suicidal Behaviors Questionnaire-Revised ≥ 7), intellectual disability (estimated IQ < 70).
Study Design
Total Participants: 84
Study Start date:
March 01, 2016
Estimated Completion Date:
May 31, 2017
Study Description
Connect with a study center
University Medical Center Hamburg Eppendorf
Hamburg, 20246
GermanySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.